Valerie Sue Hughes

Valerie S. Hughes, PhD, is a HEOR scientist and educator whose work centers on oncology real-world evidence. She holds a PhD in Health Outcomes from the University of Cincinnati College of Pharmacy, where she has served as an Adjunct Instructor since 2024 and previously worked as an HEOR Graduate Assistant. She teaches graduate courses in the use of real-world data in outcomes research and advises master’s capstone projects.

PhD: University of Cincinnati 2023 ( HEOR/RWE)

MS: University of Cincinnati 2006 (Immunology)

BS: Wright State University 2002 (Biology/Chemistry)

Research interests include administrative claims and registry-linked data, including SEER-Medicare and Medicaid, to examine treatment outcomes and drug utilization. Her dissertation evaluated overall survival in elderly patients with non-small cell lung cancer treated with PD-1 inhibitors and microbiome-altering medications.

Peer Reviewed Publications

Hughes V, Vick EJ, Schwartz R, Jandarov R, Guo J, Lin A, Hincapie AL. (2025. ) Overall survival of elderly patients with lung cancer receiving programmed death-1 (PD-1) inhibitors and antibiotics. JAPhA Pharmacotherapy. , , 2 ,

Hughes V, De Azeredo-Da-Silva A, Hincapie AL. (2019. ) Health economics and outcomes research (HEOR) knowledge needs assessment for Latin America. Value in Health Regional Issues, , 20 ,

Poster Presentations

Hughes V. (04-2023. ) Survival outcomes of elderly patients with NSCLC treated with ICI and antibiotics: a retrospective analysis using SEER-Medicare data. .Inaugural Cincinnati Conference on Pharmaceutical & Cosmetic Science, Pharmacotherapy and Personalized Healthcare;, Cincinnati, Oh. . Level:College

Hincapie A, Saverno K, Carter G, Costa L, Hughes V, Starbuck E, Heaton P. (05-2019. ) Systematic review of validation studies to identify liver, lung, brain, and bone metastases in administrative claims data .ISPOR 24th Annual International Meeting, New Orleans, LA. . Level:International

Hughes V, Guo J, Hincapie AL. (09-2018. ) Drug utilization for TNF-α inhibitors in the US Medicaid program: a retrospective analysis, 1998–2016. FIP World Congress; , Glasgow. . Level:International

Hincapie A, Almassalkhi L, Hughes V, Welch J, Wigle P, White C. (09-2017. ) Identifying patient concerns about antidepressant medications using a best-worst scaling instrument .FIP World Congress, Seoul. . Level:International

Real World Data Level:Graduate